Product NDC: | 0781-5177 |
Proprietary Name: | Ribavirin |
Non Proprietary Name: | Ribavirin |
Active Ingredient(s): | 200 mg/1 & nbsp; Ribavirin |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0781-5177 |
Labeler Name: | Sandoz Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077743 |
Marketing Category: | ANDA |
Start Marketing Date: | 20061003 |
Package NDC: | 0781-5177-42 |
Package Description: | 42 TABLET, FILM COATED in 1 BOTTLE (0781-5177-42) |
NDC Code | 0781-5177-42 |
Proprietary Name | Ribavirin |
Package Description | 42 TABLET, FILM COATED in 1 BOTTLE (0781-5177-42) |
Product NDC | 0781-5177 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Ribavirin |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20061003 |
Marketing Category Name | ANDA |
Labeler Name | Sandoz Inc |
Substance Name | RIBAVIRIN |
Strength Number | 200 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] |